For Authors & Referees

Benefits of publishing with Springer Nature
Springer Nature is a dynamic, innovative, creative company, committed to publishing high quality, independently peer-reviewed research and review material. Springer Nature uses pioneering technologies, innovative formats and world class production to provide premium information for scientific researchers in the public and private sectors, government agencies and educators.

A key strength of Springer Nature is its close relationship with the scientific community. Working closely with scientists, listening to what they say, and always placing emphasis on quality rather than quantity, has made Springer Nature the leading scientific publisher at finding innovative solutions to scientists' information needs. Publishing with the Springer Nature family provides an author with a wide range of benefits.

Springer Nature has a tradition of excellence in offering scientists the finest publication outlets in print and online.

Guide to Authors
All the key information you will require when preparing a manuscript for submission to Cancer Gene Therapy including article type specifications and formatting guidelines. Please read this section before submitting.

Editorial Policies
Information about the policies applied by the Journal and deatils of how cases of potential misconduct are dealt with. 

Editorial Process
This section explains how manuscripts are handled by our Editors between submission and acceptance for publication.

Open Access & Self Archiving
We keep our open access policies under constant review, while using a transparent approach to facilitate open science through data services, collaboration tools and public accessibility and reuse. This section provides further details on the options available to you.

Author Services
Springer Nature offers an expanse of services to authors to help aid the publication process and to maximise dissemination of your research following acceptance.

For Referees
This section contains guidelines for refereeing for Cancer Gene Therapy.